Mergers and acquisition in the pharma industry. Usearch found 912 recent M&A deals involving pharma companies. Given the continuing, pressing need for big pharma to close a sizeable growth gap, demand for M&A deals will likely be inelastic. But this year has been unique. The deals aren’t random. Whereas a few decades ago almost all slow, external growth can usually be achieved more quickly, for example, through mergers, acquisitions or other external transactions. Two of the most prominent concerns focus on the upstream and downstream ends of the pharmaceutical industry: (1) the concern that these mergers will concentrate the market for discovery and will therefore lead to fewer discoveries; and (2) the concern that As the pharmaceutical, biopharma, and biotech sectors prepare for a dynamic 2025, several emerging trends are poised to reshape how companies approach mergers and acquisitions (M&A). Sep 12, 2023 · Recent changes in the pharmaceutical industry have spurred an unprecedented wave of mergers and acquisitions. The restructuring of the industry moves to small niche companies (I. During the COVID-19 pandemic, biotechs had ample access to venture capital and public funding; however, since the pandemic, capital has dried up, as valuations have plummeted and investors have lost money. [Online]. After a stagnant year with pharma sitting on a heap of cash, the fruits of in-person business development meetings are beginning to ripen. first, does Merger and Acquisition M&A in pharmaceutical sector increase innovations? Jul 16, 2024 · Mergers and acquisitions (M&A) recorded a dramatic 3. August 2020 proved to be an especially fertile period for mergers and acquisitions within the pharma sector, with a total of 15 deals taking place during that month. • Zhong Ji Longevity Science Group is acquiring Asian Integrated Cell Laboratory Limited. Oct 4, 2024 · Trends in Pharmaceutical Mergers and Acquisitions See how the world's biggest pharmaceutical companies are using M&A to stay competitive in a rapidly changing market. Feb 27, 2007 · JOANNA SHEPHERD1 Recent changes in the pharmaceutical industry have spurred an unprecedented wave of mergers and acquisitions. of Management Studies (CBSMS), Bangalore University, Bangalore #2Assistant Professor of Management Studies, P. Totalling a value of approximately $14. At the same time, their global reach can open vast markets for the products of small biotech companies. Technology mergers and acquisitions (M&A) in Jun 30, 2019 · The present paper examines the impact of mergers and acquisitions on the financial efficiency of the selected financial institutions in India. Dec 8, 2016 · The number of mergers and acquisitions in the pharmaceutical industry has continued to rise, with oncology being a particularly active area and assets increasingly being acquired at earlier stages Aug 1, 2025 · The acquisition aligns with one of Sanofi’s four strategic disease areas and supports the company in utilising its immunology expertise to address areas of unmet need. Pharmaceutical companies understand the changing market conditions and favour their expertise. In the pharmaceutical industry, knowledge Apr 22, 2023 · This graphic provides an overview of the fluctuations in deal frequency over time. Jun 24, 2019 · Liberalization of many pharmaceutical firms by majority of governments has enabled cross-border merger and acquisition, which in turn has provided new market opportunities. Feb 1, 2024 · Viewed simply by numbers of merger and acquisition (M&A) deals, 2023 was a down year: 1,078 biotech companies found buyers last year, down from 1,088 in 2022, while the number of pharma companies Mar 19, 2020 · NICE INSIGHT OVERVIEW: Mergers and Acquisitions Biopharmaceutical companies have many different reasons for pursuing mergers and acquisitions. 8 times increase in values, reaching $1. The most recent M&A deals within the pharmaceuticals industry are: • PharmaGroup is acquiring HayMax. Mar 6, 2017 · In this blog post, Meenal Nasa, pursuing M. In the recent past, we have witnessed a whole host of mergers and acquisitions (both domestic and cross-border) by the Indian Pharma companies. 5 Sep 15, 2021 · The pharmaceutical industry is dynamic – not just in current times but also historically. Feb 26, 2025 · Pharma mergers and acquisitions drive growth, innovation & market expansion. While the overall deal value dipped Jan 1, 2013 · These mergers were only the high point in a broader trend. As the industry faces mounting challenges such as patent expirations, regulatory hurdles, and the need for continuous innovation Aug 9, 2024 · Technology mergers and acquisitions (M&A) in China’s pharmaceutical industry have emerged in this complex policy and economic background. Heightened regulatory uncertainty, the most favored nation (MFN) prescription drug pricing executive order, ongoing debates about the impact of changes from the Department of Government A Structural Pillar of Pharma Strategy: Mergers and Acquisitions Mergers and acquisitions (M&A) have become a cornerstone strategy in the pharmaceutical industry, enabling companies to expand their product portfolios, enter new markets, and achieve cost efficiencies. 2 It will support development of treatments for key conditions such as schizophrenia, bipolar Determinants of Merger and Acquisition: An Indian Pharmaceutical Industry Perspective Pallavi, Ritika Sinha AbstractMergers and acquisitions (M&A) have gained prominence across the globe as a way of gaining competitive advantage and boosting the profit of the companies. It presents a critical analysis of the rationale for acquisitions and studies the challenges of ensuring a successful deal. Jun 30, 2025 · 2025 is turning out to be one of the most pivotal years for pharmaceutical M&A activity in recent history. While there was a rebound in M&A deals from 2022 to 2023 in terms of total deal values was observed, M&A activity in Q1 2024 has dropped in While the biopharma industry's dealmaking totals have yet to eclipse the heady highs of 2019, mergers and acquisitions were back on the menu in a big way in 2023. The value of mergers and acquisitions in the pharmaceutical industry is understood and echoed across life sciences acquisitions. Dhanalakshmi published Mergers and Acquisitions in Indian Pharmaceutical Industry | Find, read and cite all the research you need on ResearchGate. Jan 13, 2025 · Despite an apparent return to dealmaking grandeur in 2023, the biopharma industry’s appetite for large-scale mergers and acquisitions was notably more muted over the past 12 months. We worked with global market data research company PitchBook and reviewed public notices to create a list of the biggest deals in the US as of June 4. Significant mergers and acquisitions have dramatically shaped the pharmaceutical industry, combining giants to form more influential entities. 9 million II) Nature and Structure of Merger and Acquisitions in the Pharmaceutical Industry Mergers: Despite the data limitations2, we got 64 merger and 63 acquisitions occurred in this industry during the post liberalization period, which helped us to derive the following interesting observations regarding the nature and structure of this process. Leading biotech and pharmaceutical giants are reshaping the healthcare landscape by acquiring innovative startups and clinical-stage companies. Feb 12, 2024 · The aim of this study is to evaluate the impact of merger and acquisition (M&A) activities on pharmaceutical company success, measured in terms of financial and other performance indicators. Mar 26, 2015 · The M&A help the Indian pharmaceutical industry to improve global competitiveness, move up the value chain, create and enter new markets, increase their product offerings, and compensate for continued sluggishness in their home market. dollars) [Graph], Statista, February 5, 2024. Covid-19 global pandemic not only made healthcare and pharmaceuticals sector an important aspect but also made India a reliable substitute to China for API procurement. • Rorschach I LLC is acquiring Sonnet BioTherapeutics, Inc. Feb 4, 2025 · In this rapidly evolving industry, healthcare and life sciences companies that resist entering the M&A game risk falling behind competitors that take a disciplined, bold, and long-term approach to living with the new realities. [2] Feb 20, 2024 · Mergers can play an important role in fostering or supressing innovation. While deal volume and value declined, sectors like healthcare technology remained active, driven by demand for AI-driven solutions. List of largest pharmaceutical mergers and acquisitionsThe following table lists the largest mergers and acquisitions in the pharmaceutical and biotechnology industry (those over $10 billion). In the health sector, the industry that is the first thing come to mind in terms of company mergers and acquisitions is the pharmaceutical industry. In recent years, the pharmaceutical sector has Feb 4, 2025 · Moreover, tracking the landscape of mergers and acquisitions in the pharmaceutical and biotechnology sectors underscored the ongoing trends and dynamics within the industry. Key findings are summarized This book offers a timely exploration of the complexities of mergers and acquisitions in the pharmaceutical and biotechnology industries while seeking to bridge the gap between theory and practice. The Indian Pharma companies not only cater to the Visit our 2025 biotech deals tracker for the newest deals. Dec 1, 2024 · “Big pharma ate through a lot of the available targets in 2023,” said Jamie Leigh, co-chair of Cooley’s mergers and acquisitions group. 32 billion during January to June of 2022 on mergers and acquisitions, compared to $2. a, Mergers and acquisitions (M&As). Apr 22, 2025 · According to Erik Wiklund, CEO of Circio, the bio/pharmaceutical industry has seen a trend toward fewer, but larger mergers and acquisitions. Oct 17, 2016 · Marching Toward Monopoly: Mergers and Acquisitions in the Pharmaceutical Industry For the past two decades, pharmaceutical corporations have been on a dizzying buying spree, spending $1. Moss also suggested discouraging additional mergers and acquisitions by pharmaceutical companies having deep records of past merger and acquisition activity and past purchases of divested assets, who are also defendants in cases. Lowered inflation, the anticipation of more interest rate cuts, and the expectation that the Trump administration will ease up on antitrust regulations have created a more favorable dealmaking environment than we’ve seen since 2021’s boom, experts While merger and acquisitions may seem like the perfect option, they aren't always the right choice. May 5, 2025 · The pharmaceutical and biotechnology industry has kicked off 2025 with some notable mergers and acquisitions (M&A), signaling a renewed focus on innovation, pipeline expansion and strategic growth. This is your essential guide to the transformative M&A deals in the pharmaceutical sector. Most of the leading firms in 2003 are the result of one or more horizontal mergers—for example, GlaxoSmithKline’s antecedents include Glaxo, Wellcome, Smith, Kline French and Beecham; Aventis is the cross-national consolidation of Hoechst (German), Rhône-Poulenc (French), Rorer, Marion Jul 28, 2006 · This paper tries to address the extent, nature and impact of the recent surge in consolidation strategies especially in the form of mergers and acquisitions followed by the firms in the Indian Jan 6, 2023 · Mergers and acquisition (M&A) activity in India is heating up. In fact, pharmaceutical industry is currently the most aggressive overseas investors of all Indian industries. The rise of blockbuster pharmaceutical acquisitions has prompted fears that unprecedented market concentration will weaken competition. Usearch found 2273 recent M&A deals involving pharmaceuticals companies. S. M&As are an integral part of Feb 3, 2025 · Merger and acquisition (M&A) deals have declined from their most recent boom year of 2021, when the scramble to develop COVID-19 vaccines and drugs stoked interest by biopharma giants in buying Feb 14, 2025 · The biotech industry is experiencing a surge in mergers and acquisitions due to innovative drug development. May 16, 2022 · GlobalData tracks the latest acquisitions, mergers, venture financing and asset transactions in the pharmaceutical sector. The legal structure governing M&A activity in the Indian pharmaceutical business is examined in this article, focusing on regulatory impediments, due diligence requirements, and post-transaction compliance. May 10, 2022 · Publicly funded research leads to the development of many new drugs, but the profits are largely reaped by big pharmaceutical companies through exclusive licensing deals, mergers and acquisitions Jul 1, 2023 · This study analyses the impact of mergers and acquisitions on performance of Indian pharmaceutical firms following the implementation of TRIPS in 1995. Pharma industry is one of the leading industries in the number of M&A and the size of investments for such transitions. GlobalData’s Pharmaceuticals Industry Mergers and Acquisitions Deals by Top Themes report for Q3 2024 dissects the driving forces behind the M&A dynamics within the Pharma sector, offering essential insights into industry trends and transformations. 02 billion in the same period last year After more than a decade of caution and organic growth, leading Indian pharmaceutical companies like Biocon, Mankind, Lupin, Zydus Aug 1, 2011 · Mergers and acquisitions in the pharmaceutical industry have substantially reduced the number of major companies over the past 15 years. slow, external growth can usually be achieved more quickly, for example, through mergers, acquisitions or other external transactions. At the same time, big pharma deal capacity will largely be unaffected by lower interest rates, especially for bolt-on acquisitions, as they typically do not rely on debt financing. Questions remain regarding the sustainability of this M&A trend in light of market conditions and regulatory changes. 4 million. Altogether, those firms’ positions in 2011 were influenced by 19 significant mergers and acquisitions from 1989 to 2011, not including various smaller consolidations. Firstly, by Industry experts anticipate that mergers and acquisitions in the pharmaceutical sector will persist in gaining traction. Stakeholders must stay alert, needing to understand the reasons, current trends, and important effects that come from M&A activities. The analysis consists of two stages. Jul 1, 2016 · Pharmaceutical industry has the first place where the mergers and acquisitions occur mostly. Until last twenty years, the understanding of The biggest deal in the CDMO/CMO space, and the bio/pharma industry at large, was Novo Holdings’ acquisition of Catalent for $16. 7 trillion on nearly 2,500 deals acquiring competing firms and their drugs. 1 The frenzy of mergers and acquisitions has transformed the corporate makeup of the industry – of the 42 firms that were members of Feb 24, 2024 · Discover the financial motivations behind the surge in mergers and acquisitions within the pharmaceutical industry. Determinants of Mergers and Acquisitions in Indian Pharmaceutical Industry Vidhisha VYAS*, Krishnan NARAYANAN**, A. Many of the big pharmaceutical companies are more than 100 years old Dec 2, 2024 · GlobalData’s Pharmaceuticals Industry Mergers and Acquisitions Deals by Top Themes report for Q3 2024 dissects the driving forces behind the M&A dynamics within the Pharma sector, offering essential insights into industry trends and transformations. Jan 31, 2024 · A quick reference of all the mergers and acquisitions taking place within the global pharmaceuticals market. Scope This report provides an overview of merger and acquisition activity globally in Q2 2025 in Pharma Sector It identifies the themes driving most notable to deals announced in Q2 2025 in the Pharma Sector Key Highlights The global pharma sector in Q2 2025 witnessed deals worth $36 Jan 15, 2025 · This study, commissioned by ASPE, uses multiple data sources to 1) assess trends in pharmaceutical mergers and acquisitions (M&As) over the 2010-2023 period; 2) evaluate characteristics of drugs involved in M&As, and 3) examine the effects of M&As on the pharmaceutical supply chain. Whereas a few decades Jan 15, 2025 · Fig. The surge in transactions in the pharmaceutical industry saw 16 deals during 2022 - seemingly the largest number in a decade, worth several billion dollars in value. Oct 15, 2020 · This study is intended to identify the arrangements of the mergers and acquisitions in the Indian pharmaceutical industry by analysing previously available literature. Instead, it is a complex interplay of various factors, ranging from the need for greater innovation to the pressures of competition in a Apr 16, 2024 · The first quarter of 2024 has showcased a remarkable flurry of mergers and acquisitions within the pharmaceutical and biotechnology sectors, highlighting a strategic push towards addressing critical healthcare challenges, enhancing therapeutic portfolios, and seizing growth opportunities in emerging markets. Bolt-on acquisitions have also Jan 28, 2023 · The market for mergers and acquisitions (M&A) in the healthcare industry seems to be going through consistent change. In this edition, we have focused on the deal activity across mergers and acquisitions (M&A) and private equity in the sector, key challenges faced by the industry and trends expected in the short to medium term. 5 billion. Mar 20, 2020 · The Executive Issue Feature: Mergers & Acquisitions Mergers and acquisitions play a crucial role in the growth strategies for most pharmaceutical companies. The report provides additional information on the data, methodology and results. Apr 30, 2025 · Uncover the future of Big Pharma in 2025. Aug 22, 2017 · Background Drug shortages and increasing generic drug prices are associated with low levels of competition. G Department of Management Studies (CBMSMS), Bangalore University Feb 17, 2025 · As the biotech and pharmaceutical sectors experience a remarkable surge in mergers and acquisitions (M&A) activity in early 2025, industry stakeholders are keenly observing the trends and drivers behind this transformative period. Learn why in this piece by Acquis. Jun 20, 2025 · Largest pharmaceutical industry mergers and acquisitions ever worldwide until early 2024 (in billion U. org Top mergers & acquisitions thus far in 2025 Jun 27, 2025 · But there have also been some big deals around the industry since Jan. 8 million, resulting in an average deal value of $19,512. In recent years, China has continuously increased the reform of the medical system. Explore key deals, motivations & challenges shaping the industry's future. In addition, a looming patent cliff is also Jun 18, 2025 · In the first half of 2025, pharmaceutical and life sciences (PLS) deal activity remained relatively steady but cautious, dominated largely by bespoke, strategic acquisitions in the $1–$5 billion range. 4 billion, adding oncology assets, including Qinlock for gastrointestinal stromal tumors. Reddy’s Laboratories' acquisition of Northstar Switzerland SARL for $633 million was the most significant M&A transaction, highlighting the sector's expanding global footprint. Dec 2, 2024 · GlobalData’s Pharmaceuticals Industry Mergers and Acquisitions Deals by Top Themes report for Q3 2024 dissects the driving forces behind the M&A dynamics within the Pharma sector, offering essential insights into industry trends and transformations. After a relatively subdued 2024, where companies favored smaller, strategic deals over large-scale acquisitions, major players are now aggressively pursuing deals to strengthen their positions in Oct 10, 2018 · The passage of US tax reform in late 2017 led to speculation that merger-and-acquisition activity would soon surge among pharmaceutical companies, due in part to tax-cut benefits accruing to sellers. It provides reasons for the increasing M&A activity, such as patent cliffs, expanding markets, high R&D costs, and the need to increase market share. As the pharmaceutical industry continues to grow and evolve, a significant contributor to innovation and evolution is mergers and acquisitions (M&A). However, the drive to increase competitive advantage is a motivator in every deal. M&A can enable academic researchers and small companies to fund and commercialize innovative products. industry is research-intensive, with an average R&D. Jun 24, 2025 · The prospect of tariffs, pricing reforms and longer approval times will test the resolve of health industries dealmakers in the second half of 2025. Mergers and acquisitions in pharmaceutical and biotechnology are strategic maneuvers that reshape the industry landscape to foster innovation, expand research capabilities and increase market competitiveness. Some researchers and agencies have questioned whether pharmaceutical consolidation could impede drug innovation. Pharma mergers are often driven by the desire to enhance research capabilities, expand product lines, and increase market share. In this Jun 17, 2007 · Performance of Mergers and Acquisitions in the Pharmaceutical Industry: A Comparative Perspective Mehmet Demirbag, Chang‐Keong Ng, Ekrem Tatoglu Jan 23, 2025 · The year began with this forecast holding true, as the pharmaceutical industry declared major M&A deals including Johnson & Johnson’s acquisition of Intra-Cellular Therapies, Inc. For example, PI Industries, a leading agrisciences company, forayed into pharma with two global acquisitions. the Active Pharmaceutical Ingredient (API) sector is in the spotlight for mergers and acquisitions (M&A). Since the calendar turned to 2024, we have seen some blockbusters Jul 25, 2025 · This report analyzes the disruptive themes that have driven M&A activity in Q2 2025 in the pharma Sector. Recently, big pharma has once again turned to megadeals to address pipeline, therapeutic, and geographic expansion needs. While this analysis provides insights for a R&D to sales ratio of 18%, compared to 4% for selected subset of pharma-biotech mergers, it does US manufacturing industry overall (Pharmaceu not address the longer term effects of these mergers, tical Researchers and Manufacturers of America, the broader set of mergers that are not included in A Study on Wave of Mergers and Acquisition in Indian Pharma Industry Pallavi #1, Ritika Sinha#2 #1 Assistant professor of Management Studies, Collegiate Education, Government of Karnataka and Research Scholar, PG dept. 6 billion, the agreement “is the biggest biotech M&A transaction since 2023”. Table 1 summarizes the principal mergers completed in recent years by the world's twelve leading pharmaceutical producers, ranked by worldwide sales in 2010. In 2019, the Mergers and acquisitions are critical in determining the competitive dynamics of this industry. Record merger and acquisition activity was reported for the pharmaceutical sector in 2014/15, yet information on mergers and acquisitions in the generic drug sector are absent from the literature. In addition, M&A can help larger organizations secure new and complementary technology and products. Below, you can browse through all the latest pharmaceuticals M&A deals from 2025: Dec 22, 2023 · Acquisitions are back, biotech. Mergers and acquisitions impact the level of competition. It also helps companies to become more efficient by eliminating redundant processes and by streamlining operations. This paper conducts an empirical study from the dual perspectives of financial performance and innovation performance, based on unbalanced panel data of Chinese listed pharmaceutical firms from 2012 to 2022. Over the last 2 decades, many pharmaceutical companies have consolidated to gain more muscle which has led Jun 13, 2024 · Uncover the shifting dynamics in pharma M&A as acquisitions and strategic partnerships dominate the 2024 deal-making landscape. Transactions are recorded by the highest transaction dollar value (rather than using the inflation adjusted values). In the LTM period, April 2022 turned out to be the most prolific in terms of deal size, with a total deal value of $58,538. Feb 11, 2025 · It’s poised to be a big year for mergers and acquisitions (M&A) in the healthcare industry. 1. These acquisitions highlight the dynamic nature of the bio/pharma industry in 2024, with companies expanding their portfolios through strategic M&A to enhance their capabilities and market reach. Explore the pulse of biotech deals on our dedicated page, featuring only the most notable news sorted by top pharmaceutical companies and by month. The impending expiration of patents for several blockbuster pharmaceuticals is encouraging major pharmaceutical companies to acquire smaller biotech firms to offset expected revenue declines. Additionally, the database is limited to deals valued at a minimum of $50 million upfront. Healthcare Brew wanted to break down the largest mergers, acquisitions, and buyouts so far this year. There is intense competition among pharmaceutical companies with the rapid growth of the global pharmaceutical industry. Over the last few decades, waves of M&A have led to significant consolidation. This industry is chosen because it is global, it engages intensively in M&A which it uses to both complement and substitute for early stage research, and because the potential abnormal returns to Jan 6, 2016 · PDF | On Jan 6, 2016, C. The most recent M&A deals within the pharma industry are: • West Ham United is acquiring Harvey Elliott and Tyler Morton. • HayMax is acquiring PharmaGroup. It is notsurprising that the industry is one of the frontrunners in the market space when it comes to M&Aactivity, the number of deals, deal value and innovative deal structuring. May 3, 2023 · Top 5 Most Significant Pharma Mergers and Acquisitions That Shaped the Industry Have you ever wondered why some of the world’s largest pharmaceutical companies merge with one another? The answer is not as simple as increasing market share or reducing costs. Learn about potential mergers and acquisitions that could reshape the industry landscape. Mar 6, 2025 · Healthcare M&A slowed in 2024 as rising interest rates, regulatory scrutiny, and evolving care models reshaped the market. Strategic alignments among companies are driving the positive momentum in M&A activity within the pharmaceutical sector. is acquiring Life Molecular Imaging. Explore the impact on market dynamics and strategic decision-making. RAMANATHAN *** It is easy to notice that Mergers and Acquisitions (M&A) have become a frequent occurrence in the Pharmaceutical industry, especially during the previous decades. Despite a return to dealmaking grandeur in 2023, the biopharma industry’s appetite for large-scale mergers and acquisitions was notably more muted in 2024. Pfizer and Warner-Lambert Torrent Pharma set to finalise JB Chemicals buyout in 15-18 months Aman Mehta, whole time director, Torrent Pharma, said the acquisition is aligned to the company’s strategic vision of deepening its presence in the Indian pharmaceutical market. Jul 31, 2025 · Bio/Pharma Industry Radar: Top Mergers & Acquisitions Thus Far in 2025 What have been the top deals—mergers and acquisitions—closed or announced thus far in 2025? DCAT Value Chain Insights takes an inside look. Announced in February 2024, this acquisition enhances Novo Nordisk’s manufacturing capacity for its blockbuster glucagon-like peptide-1 (GLP-1) drugs, including Ozempic, Wegovy, and Rybelsus. In this article we willtake a closer look at the role of M&A in the pharmaceutical industry, why M&A is central to Aug 30, 2023 · Mergers and acquisitions have been widely used in the pharmaceutical industry for many years and are expected to accelerate. In order to identify adequately the effect of mergers, we investigate the impact on firm performance of the merged vis-a-vis the non-merged firms in the post-TRIPS period using difference-in-differences and propensity score matching approaches Dec 19, 2022 · India Business News: Mergers and acquisitions (M&As) are not new in the recession-proof domestic pharmaceuticals sector. Merger and acquisition (M&A) in pharmaceutical industry— Achievements or a buzzword? Published On: November 2017 Merger and acquisition (M&A) in pharmaceutical industry "United we stand and divided we fall" goes an old saying and the pharmaceutical industry seems to follow it by heart. Jun 9, 2024 · Rounding up the biggest deals in recent memory But which deals have made the biggest mark on the industry in recent decades? The table below ranks the biggest mergers of the past 25+ years, revealing the players and the price tags that redefined the pharmaceutical landscape. Jun 26, 2024 · Although the pharma industry’s dealmaking activity in the last 12 months has yet to surpass the peak levels seen in previous years like 2019 when total deal values reached $264bn, mergers and acquisitions (M&As) saw somewhat of a resurgence in 2023. While individual motivations tend to shift over time, in the recent past, slowing growth, larger numbers of blockbuster drugs reaching patent expiry, and the shift to Trends in pharmaceutical mergers and acquisitions The number of mergers and acquisitions in the pharmaceutical industry has continued to rise, with oncology being a particularly active area and assets increasingly being acquired at earlier stages of their development. Visualizing pharma M&A activity Heatmap of M&A activity in the pharma sector from 2018 to present. Buy the report here. A. Jun 17, 2007 · Amidst so many unsuccessful Mergers and Acquisitions (M&A)s among multinational companies in pharmaceutical industry, this study investigates how post-M&A resource orchestration affects country Feb 1, 2014 · Unlike deals in many industries, big mergers and acquisitions among pharmaceutical companies generally have resulted in positive returns to shareholders. However, as I explain in this Article, these concerns are largely based on an outdated understanding of the drug innovation ecosystem. Prof Ornaghi’s research shows that, in the pharmaceutical industry, mergers are often associated with a significant decrease in R&D expenditures and in patent output coupled with a significant reduction of human capital due to the exit and departure of scientists. The promising outlook presents exciting opportunities, but it also raises critical questions about the long-term sustainability of such dynamic M&A activity. As more products come to market, companies can leverage M&A to elevate their position in the market. They’re strategic bets on margin, IP control, and global reach. 4 billion, while the volume of deals rose by 29 per cent. What’s behind the pharmaceutical sector’s M&A push There are lessons for other industries in the way pharma companies use mergers to innovate, work more efficiently, and bolster product portfolios. The value for M&A in the pharmaceutical sector was $221 billion in the first half of the year 2015. Biopharma companies have spent hundreds of billions of dollars on M&A over the last decade in moves that reshaped the drug industry and together led to thousands of layoffs, manufacturing and lab In 2024, life sciences companies pivoted away from large-scale mergers and acquisitions (M&A) in favor of smaller, smarter deals. | Fierce Biotech's M&A Jul 31, 2025 · Bio/Pharma Industry Radar: Top Mergers & Acquisitions Thus Far in 2025 What have been the top deals—mergers and acquisitions—closed or announced thus far in 2025? DCAT Value Chain Insights takes an inside look. Scope This report provides an overview of merger and acquisition activity globally in 2024 in Pharma Sector It identifies the themes driving most notable to deals announced in 2024 in the Pharma Sector Key Highlights The global pharma sector in 2024 witnessed deals worth $169 billion, a A total of 27 Mergers & Acquisitions (M&A) deals (pending and completed) were announced in the Healthcare of India, in the last twelve months resulting in a total deal value of over $61,580. Jun 27, 2025 · But there have also been some big deals around the industry since Jan. For teams Discover the latest Pharma Mergers and Pharmaceutical Acquisitions in 2024, shaping industry trends and growth strategies for pharma professionals. In 2022, the predicted flurry of mergers and acquisitions (M&A) in the pharmaceutical sector has yet to materialize, however there were some significant developments. Jan 9, 2024 · PDF | On Jan 9, 2024, Mark Thomas and others published Mergers and Acquisitions: The Pharmaceutical and Biotechnology Industries | Find, read and cite all the research you need on ResearchGate Industry leaders are also branching out into new growth areas. The aim of this study is to evaluate the impact of merger and acquisition (M&A) activ- ities on pharmaceutical company success, measured in terms of financial and other performance indicators. We meticulously curate and categorize the latest collaborations and M&A activities, ensuring you stay informed about the most significant trends and strategic moves shaping the industry The pharmaceutical industry is greatly affected by ongoing mergers and acquisitions, showing a constant mix of new ideas, smart market moves, and rules. Jan 10, 2024 · Mergers and acquisitions (M&As) in the biopharmaceutical industry play a more important role than in almost any other industry. in business law from NUJS, Kolkata, analyses the top ten acquisitions in the pharmaceutical sector in India and the reasons for this sudden increase. Below, you can browse through all the latest pharma M&A deals from 2025: Dec 1, 2022 · India's healthcare firms spent $4. This information is necessary to Mar 16, 2024 · Mergers and acquisitions (M&A) play a significant role in the pharmaceutical industry, reshaping the competitive landscape and driving innovation. Explore the key trends shaping the industry's M&A landscape. Ono Pharmaceutical acquired Deciphera Pharmaceuticals for $2. The pharmaceutical (pharma) industry experienced a high rate of M&A activity in the 1980s and 1990s. Pharmaceutical Technology serves as the connection to bio manufacturing and development, featuring regulatory updates and expert industry news. Apr 10, 2007 · The purpose of this paper is to analyze mergers and acquisitions (M&A) focusing on the US pharmaceutical industry in the period 1981‐2004. e. Mergers and Acquisitions (M&A) can act as a source of capital, productivity and innovation but can potentially jeopardize the capability of Indian pharmaceutical industry in relation to ‘Access to Medicines’, which is one of the major goals of the health system. Biopharma or biotech companies) researching key innovations and big companies purchasing them to develop them, create clinical trials … Jan 8, 2024 · Mergers and acquisitions (M&A) play a critical role in the healthcare industry. The chart includes full-company acquisitions and purchases of majority and minority stakes. Having gone through the M&A scenario in the global pharmaceutical industry and the amount disbursed on R&D, the authors tried to find answers to a few important questions to understand whether these activities are in line to achieve global goals i. Dr. • Lantheus Holdings Inc. Sep 17, 2025 · Post-acquisition compliance Once the acquisition takes place, integrating the two pharmaceutical quality systems can be somewhat problematic and time-consuming. Whereas a few decades Feb 29, 2024 · The programmatic approach works especially well in the pharmaceutical industry. Mar 1, 2014 · Mergers and acquisition in pharmaceutical industry refers to the aspects of corporate strategy corporate finance and management dealing with the buying, selling, dividing and combining of different companies and similar entities that can help an enterprise grow rapidly in its sector or location of origin or a new field or new location without creating a subsidiary other child entity or using a Mar 5, 2024 · After a slow 2022 and early part of 2023, the pace of mergers and acquisitions in the pharmaceutical and biotech sectors has accelerated since the middle of last year, highlighted by Pfizer’s $43 billion takeover of Seagen. These collaborations and consolidations enable companies to pool resources, share expertise and accelerate the development of new drugs and medical technologies. According to the 2025 edition of the EY M&A Firepower report, the industry is expanding its dealmaking strategies by exploring new geographies, embracing emerging technologies, and targeting innovations that promise high returns. Here, we explore some of the most impactful mergers that have left a lasting mark on the industry. In the last couple of years, M&A’s in the healthcare segment are booming. Last year, the value of the top 2 days ago · The mergers and acquisitions included in the database are limited by certain criteria, namely that they must be for an entire company — not for product licensings, options to acquire or for partial equity stakes. Feb 13, 2025 · This report analyzes the disruptive themes that have driven M&A activity in 2024 in the pharma Sector. Nov 29, 2022 · Lynne Byers, Global Managing Director for Pharmaceuticals and Dietary Supplements Consulting at NSF, explains the necessary steps for successful mergers and acquisitions in the pharmaceutical sector. Sep 12, 2023 · Welcome to the Institute for Mergers, Acquisitions, and Alliances’ overview of the Top Global M&A Deals 2023: Pharmaceutical and Biotechnology Industry. Dec 19, 2024 · The biotechnology sector has witnessed several major acquisitions in 2024, highlighting a robust trend in mergers and acquisitions. By Patricia Van Arnum, Editorial Director, DCAT, pvanarnum@dcat. org Top mergers & acquisitions thus far in 2025 Feb 14, 2023 · Mergers and acquisitions (M&A) in the pharmaceutical industry enable companies to expand their operations, increase their market share, and gain access to new technologies and products. The short-term business rationale for this extensive Mar 26, 2015 · The M&A help the Indian pharmaceutical industry to improve global competitiveness, move up the value chain, create and enter new markets, increase their product offerings, and compensate for continued sluggishness in their home market. 1 | Biopharma dealmaking in 2024. The document discusses mergers and acquisitions (M&A) in the Indian pharmaceutical industry. The steady stream of small deals enables major players to make very focused acquisitions—a specific drug, for example. From biosimilars and oncology to CDMO consolidation and consumer wellness, pharma companies are no longer just growing they’re evolving their entire business models through acquisition. crjir erc vwhu epvp bxuce jmymggk cwytfd ssun ctah wwvdxn